Reusable Lancing Device Global Market Report 2026

Reusable lancing devices are handheld medical devices used to collect small capillary blood samples through skin puncture, primarily for blood glucose monitoring in diabetic patients. These devices utilize replaceable sterile lancets and include adjustable penetration depth features to ensure safer, more comfortable, and cost-effective blood sampling for repeated applications.

The primary product types of reusable lancing devices include automatic lancing devices and manual lancing devices. Automatic lancing devices refer to reusable medical devices designed to create controlled skin punctures for collecting capillary blood samples with adjustable depth settings and enhanced patient comfort. The various applications include blood sample collection and blood glucose monitoring, and these devices are utilized by end users including hospitals, clinics, and diagnostic centers.

Tariffs are influencing the reusable lancing devices market by increasing the cost of imported sterile lancets, medical-grade plastics, precision springs, and molded components required for device manufacturing. The impact is most significant on automatic lancing devices, particularly safety-engineered automatic lancing devices and adjustable-depth automatic lancing devices, while blood glucose monitoring applications are facing higher procurement costs. Regions dependent on imported medical device components, including Asia-Pacific and North America, are experiencing supply chain disruptions and pricing pressures. However, tariffs are also promoting domestic manufacturing expansion, supplier diversification, and increased investment in regional medical device production ecosystems, improving long-term supply chain resilience and market stability.

The reusable lancing device market research report is one of a series of new reports from The Business Research Company that provides reusable lancing device market statistics, including reusable lancing device industry global market size, regional shares, competitors with a reusable lancing device market share, detailed reusable lancing device market segments, market trends and opportunities, and any further data you may need to thrive in the reusable lancing device industry. This reusable lancing device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The reusable lancing device market size has grown strongly in recent years. It will grow from $14.43 billion in 2025 to $15.85 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to rising prevalence of diabetes worldwide, increasing awareness regarding regular blood glucose monitoring, growth in hospital and diagnostic testing volumes, advancements in lancet and lancing device safety features, expanding access to diabetes management programs.

The reusable lancing device market size is expected to see rapid growth in the next few years. It will grow to $23.25 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to growing adoption of home healthcare monitoring solutions, increasing demand for patient centric blood sampling devices, expansion of preventive healthcare screening programs, rising healthcare expenditure in emerging economies, development of more ergonomic and user friendly reusable lancing devices. Major trends in the forecast period include increasing adoption of safety engineered lancing devices for needlestick injury prevention, growing demand for adjustable depth lancing devices for personalized blood sampling, rising preference for reusable lancing devices to reduce long term monitoring costs, expansion of home based blood glucose monitoring practices, development of low pain blood sampling technologies for improved patient comfort.

The increasing global prevalence of diabetes is expected to drive the growth of the reusable lancing device market going forward. Diabetes is a chronic metabolic condition that occurs when the body is unable to properly regulate blood glucose levels due to inadequate insulin production or reduced insulin effectiveness. The growing prevalence of diabetes worldwide is being driven by rising obesity rates associated with sedentary lifestyles and unhealthy dietary patterns. Reusable lancing devices support diabetes management by providing patients who require frequent testing with convenient, accurate, and cost-efficient blood glucose monitoring solutions. For instance, in April 2024, according to the International Diabetes Federation, a Belgium-based non-profit diabetes organization, the number of adults living with diabetes reached 589 million in 2024 and is expected to rise to 853 million by 2050, reflecting an estimated increase of nearly 44.8%. Therefore, the rising global prevalence of diabetes is contributing to the growth of the reusable lancing device market.

Major companies operating in the reusable lancing device market are increasingly focusing on developing advanced, user-friendly blood sampling technologies, such as cap-free reusable lancing systems with concealed-needle mechanisms, to enhance patient comfort, simplify blood collection processes, and improve convenience in diabetes self-monitoring. Cap-free reusable lancing systems are blood sampling devices designed for multiple uses that eliminate the requirement for a protective cap, enabling users to directly cock and activate the lancing mechanism for faster and more convenient operation. For instance, in June 2025, SteriLance Medical, a China-based medical device manufacturer, launched the Onestep Lancing Device in Europe. The reusable lancing device incorporates a cap-free design and hidden-needle technology that minimizes preparation steps during blood sampling procedures. The system is developed to enable safer and more convenient capillary blood collection while enhancing usability for diabetes patients performing routine self-monitoring of blood glucose (SMBG). The launch expands the company's diabetes care portfolio by addressing the growing demand for simplified and patient-focused reusable lancing solutions in home healthcare environments.

In March 2024, Medical Technology and Devices (MTD), an Italy-based manufacturer of medical devices and diabetes care solutions, acquired the pen needle and blood glucose monitoring (BGM) businesses of Ypsomed Holding AG for an undisclosed amount. Through this acquisition, Medical Technology and Devices (MTD) sought to strengthen its global diabetes care portfolio by expanding its blood glucose monitoring capabilities, increasing pen needle manufacturing capacity, and reinforcing its position in the diabetes self-care market. Ypsomed Holding AG is a Switzerland-based developer of diabetes care solutions, including blood glucose monitoring systems, pen needles, insulin delivery devices, and self-management technologies for diabetes patients.

Major companies operating in the reusable lancing device market report are F. Hoffmann-La Roche AG, Abbott Laboratories, Becton Dickinson and Company, B. Braun SE, Terumo Corporation, Nipro Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc., MED TRUST Handelsges.m.b.H., TaiDoc Technology Corporation, Bionime Corporation, Visiomed Group SA, Norditalia Elettromedicali S.r.l., Pharma Supply Inc., KETO-MOJO, LaMeditech Co. Ltd., Nova Diabetes Care, MHC Medical Products LLC, Owen Mumford Ltd., Boen Healthcare Co. Ltd., LifeScan Inc., AgaMatrix Inc., GlucoRx Ltd., Osang Healthcare Co. Ltd., Major Bioscience Co. Ltd.

North America was the dominating region in the reusable lancing device market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the reusable lancing device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the reusable lancing device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The reusable lancing device market consists of sales of reusable blood sampling devices, lancets, adjustable lancing pens, and related accessories. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Reusable Lancing Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses reusable lancing device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for reusable lancing device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The reusable lancing device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Automatic Lancing Devices; Manual Lancing Devices
• 2) By Application: Blood Sample Collection; Blood Glucose Monitoring
• 3) By End User: Hospitals; Clinics; Diagnostic Centers
• Subsegments:
• 1) By Automatic Lancing Devices: Adjustable Depth Automatic Lancing Devices; Fixed Depth Automatic Lancing Devices; Safety Engineered Automatic Lancing Devices With Needle Shield Or Retractable Needle
• 2) By Manual Lancing Devices: Twist Action Manual Lancing Devices; Push Button Manual Lancing Devices; Adjustable Depth Manual Lancing Devices
• Companies Mentioned: F. Hoffmann-La Roche AG; Abbott Laboratories; Becton Dickinson and Company; B. Braun SE; Terumo Corporation; Nipro Corporation; Ascensia Diabetes Care Holdings AG; ARKRAY Inc.; MED TRUST Handelsges.m.b.H.; TaiDoc Technology Corporation; Bionime Corporation; Visiomed Group SA; Norditalia Elettromedicali S.r.l.; Pharma Supply Inc.; KETO-MOJO; LaMeditech Co. Ltd.; Nova Diabetes Care; MHC Medical Products LLC; Owen Mumford Ltd.; Boen Healthcare Co. Ltd.; LifeScan Inc.; AgaMatrix Inc.; GlucoRx Ltd.; Osang Healthcare Co. Ltd.; Major Bioscience Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.